High CTR1 expression was associated with increased TR (OR = 2.99, 95% CI: 1.57-5.69, P = 0.001), especially in the subgroups of “ovarian cancer” (OR = 2.28, 95% CI: 1.15-4.54, P = 0.019), “lung cancer” (OR = 5.64, 95% CI: 2.17-14.65, P = 0.000), “Asia” (OR = 6.39, 95% CI: 2.83-14.41, P = 0.000), “dataset” (OR = 1.61, 95% CI: 1.10-2.37, P = 0.015), “literature” (OR = 6.39, 95% CI: 2.83-14.41, P = 0.000), “gene array” (OR = 1.61, 95% CI: 1.10-2.37, P = 0.015) and “IHC” (OR = 5.64, 95% CI: 2.17-14.65, P = 0.000) subgroups. Here, SLC31A1 is linked to lung cancer.